ArticleJournal of clinical medicine2025
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration.
Katja Hatz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.